Co-loaded paclitaxel/rapamycin liposomes: Development, characterization and in vitro and in vivo evaluation for breast cancer therapy

Paclitaxel and rapamycin have been reported to act synergistically to treat breast cancer. Albeit paclitaxel is available for breast cancer treatment, the most commonly used formulation in the clinic presents side effects, limiting its use. Furthermore, both drugs present pharmacokinetics drawbacks...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Colloids Surf B Biointerfaces
Egile Nagusiak: Eloy, Josimar O., Petrilli, Raquel, Topan, José Fernando, Antonio, Heriton Marcelo Ribeiro, Barcellos, Juliana Palma Abriata, Chesca, Deise L., Serafini, Luciano Neder, Tiezzi, Daniel G., Lee, Robert J., Marchetti, Juliana Maldonado
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2016
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4957969/
https://ncbi.nlm.nih.gov/pubmed/26836480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.colsurfb.2016.01.032
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak